The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity
Quinolones are broad-spectrum synthetic antibacterial drugs first obtained during the synthesis of chloroquine. Nalidixic acid, the prototype of quinolones, first became available for clinical consumption in 1962 and was used mainly for urinary tract infections caused by Escherichia coli and other p...
Main Authors: | Abdul Naeem, Syed Lal Badshah, Mairman Muska, Nasir Ahmad, Khalid Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/4/268 |
Similar Items
-
Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones—Shaping the Fifth Generation
by: Aura Rusu, et al.
Published: (2021-08-01) -
Mini Review: Is fluoroquinolone drug or poison?
by: Fatima Zohra Mimouni, et al.
Published: (2019-12-01) -
Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2021-04-01) -
Rapid Identification of Mutations in Quinolone-Resistant Shigella Isolates by Scanning of gyrA and parC Genes using High-Resolution Melting Curve Analysis
by: Mohammad Mehdi Soltan Dallal, et al.
Published: (2020-05-01) -
A RADAR-Based Assay to Isolate Covalent DNA Complexes in Bacteria
by: Katie J. Aldred, et al.
Published: (2019-02-01)